InvestorsHub Logo
Followers 7
Posts 1577
Boards Moderated 0
Alias Born 02/27/2014

Re: None

Sunday, 02/01/2015 8:41:11 AM

Sunday, February 01, 2015 8:41:11 AM

Post# of 80868
The low valuation of Musclepharm gotta be a slap in the face of Brad.

Before the announcement of results and the conference call, the "invest" worthiness was stellar, but after it was gone.

The numbers were not promising for the near future and the mumbling about vertical integration, when the company is so low on cash, didn't fly high with investors.

So, Brad is increasingly up against the wall, and if he doesn't deliver in 2015, I think the conference calls are gonna be tough on him.

He has accomplished a lot though, you gotta give that credit to him, but it's time for him to get the pieces together....to plan cost savings, preferably from a position of profitability.

Profitability doesn't come from over sized salaries and stock grants, because cash is needed and stocks may be needed for expansion. If stocks are issued too frequently, the stock becomes worthless just from the anticipation of more stocks.